Early cerebellar hypometabolism in patients with frontotemporal dementia carrying the C9orf72 expansion

Alzheimer Disease and Associated Disorders

Volumn 29, Issue 4, 2015, Pages 353-356

  Suárez Calvet, Marc ^a   Camacho, Valle ^b   Gómez Ansón, Beatriz ^b   Antón, Sofia ^a   Vives Gilabert, Yolanda ^b   Dols Icardo, Oriol ^a   Clarimón, Jordi ^a   Alcolea, Daniel ^a   Blesa, Rafael ^a   Fortea, Juan ^a   Lleó, Alberto ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

18F FDG PET; C9orf72; Frontotemporal dementia; Neuroimaging

Indexed keywords

APOLIPOPROTEIN E; FLUORODEOXYGLUCOSE F 18; LEVOTHYROXINE; PREDNISONE; C9ORF72 PROTEIN, HUMAN; PROTEIN; REPETITIVE DNA;

ADULT; ALZHEIMER DISEASE; APRAXIA; ARTICLE; BEHAVIOR CHANGE; BRAIN METABOLISM; CAG REPEAT; CASE REPORT; CEREBELLUM ATROPHY; CEREBROSPINAL FLUID ANALYSIS; CHROMOSOME 9 OPEN READING FRAME 72 GENE; COGNITION; DISORIENTATION; EXECUTIVE FUNCTION; FAMILY HISTORY; FLUENCY DISORDER; FOLLOW UP; FOOD PREFERENCE; FRONTAL VARIANT FRONTOTEMPORAL DEMENTIA; GENE; GENETIC ANALYSIS; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; HETEROZYGOSITY; HUMAN; HYPERREFLEXIA; HYPOTHYROIDISM; IMPULSIVENESS; IRRITABILITY; MALE; MEMORY DISORDER; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSESSION; OPEN READING FRAME; PARIETAL LOBE; PERSONALITY DISORDER; PET-CT SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSIVE NONFLUENT APHASIA; RECALL; SOUTHERN BLOTTING; SYSTEMIC LUPUS ERYTHEMATOSUS; VERBAL MEMORY; VISUAL HALLUCINATION; CEREBELLUM; FRONTOTEMPORAL DEMENTIA; GENETICS; METABOLISM; SCINTISCANNING;

ADULT; CEREBELLUM; DNA REPEAT EXPANSION; FRONTOTEMPORAL DEMENTIA; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROTEINS;

EID: 84947936776     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0000000000000056     Document Type: Article

References (12)

1. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245-256.
2. Renton AE, Majounie E, Waite A, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257-268.
3. Boeve BF, Boylan KB, Graff-Radford NR, et al. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain. 2012;135:765-783.
4. Savica R, Adeli A, Vemuri P, et al. Characterization of a family with c9FTD/ALS associated with the GGGGCC repeat expansion in C9ORF72. Arch Neurol. 2012;69:1164-1169.
5. Whitwell JL, Weigand SD, Boeve BF, et al. Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics. Brain. 2012;135:794-806.
6. Cistaro A, Pagani M, Montuschi A, et al. The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients. Eur J Nucl Med Mol Imaging. 2014; 41:844-852.
7. Dols-Icardo O, Garcia-Redondo A, Rojas-Garcia R, et al. Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia. Hum Mol Genet. 2014;3:749-754.
8. Dols-Icardo O, Suarez-Calvet M, Hernandez I, et al. Expansion mutation in C9ORF72 does not influence plasma progranulin levels in frontotemporal dementia. Neurobiol Aging. 2012;33: e17-e19.
9. Devenney E, Hornberger M, Irish M, et al. Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile. JAMA Neurol. 2014;71:331-339.
10. Weiner SM, Otte A, Schumacher M, et al. Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET. Ann Rheum Dis. 2000;59:377-385.
11. Pearson JP, Williams NM, Majounie E, et al. Familial frontotemporal dementia with amyotrophic lateral sclerosis and a shared haplotype on chromosome 9p. J Neurol. 2011; 258:647-655.
12. Al-Sarraj S, King A, Troakes C, et al. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Acta Neuropathol. 2011;122:691-702.